THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE AND AFFILIATES: Single Audit Reports and Findings

THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE AND AFFILIATES's most recent single audit in the Federal Audit Clearinghouse covers fiscal year 2016, accepted August 15, 2017; the auditor observed on that filing is Ernst & Young LLP. It reported 1 finding. 1 filing in 2016 is on record. Data as of 2026-11-06.

Data as of Nov 6, 2026 · Source: Federal Audit Clearinghouse (public data)

Single audits by year

One row per audit year as the Federal Audit Clearinghouse accepted it. The auditor named is the one observed on that filing; THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE AND AFFILIATES is recorded in PHOENIX, Arizona under EIN 753065445, and the Clearinghouse records it as a nonprofit. Each report opens on the Clearinghouse itself; how to search the Federal Audit Clearinghouse explains the rest of the reporting package.

Single audits filed by THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE AND AFFILIATES
Audit yearFiscal year endFederal expendedThreshold appliedAuditor observedOpinionFindingsMW / SDFAC report
20162016-11-16$6,458,864$750,000Ernst & Young LLPUnmodified1SD2016-11-CENSUS-0000234403

When is the next single audit due?

If THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE AND AFFILIATES is again required to have a single audit for the fiscal year ending Nov 16, 2017, the reporting package is due to the Federal Audit Clearinghouse by Aug 16, 2018 at the latest.

No filing for that fiscal year appears in the Clearinghouse data as of Nov 6, 2026. The data does not show why: an organization below the threshold is not required to file, and a filing can be accepted after the due date.

Whether an audit is required depends on federal awards expended in that year (the single audit threshold). The rule, 2 CFR 200.512(a): the reporting package is due within 30 calendar days after the auditee receives the auditor's report or nine months after the end of the audit period, whichever is earlier; the date above is the nine-month date, moved to Monday when it falls on a weekend. Last verified: 2026-11-15.

Which federal programs did this organization report?

From the most recent accepted report, as listed on its schedule of expenditures of federal awards (SEFA). "Major" is the designation the auditor made under 2 CFR 200.518, not ours.

Federal programs on the most recent report
ALNProgramExpendedMajor
93.310TRANS-NIH RESEARCH SUPPORT$1,165,488Yes
93.395CANCER TREATMENT RESEARCH$671,360Yes
93.394CANCER DETECTION AND DIAGNOSIS RESEARCH$616,029Yes
93.866AGING RESEARCH$473,616Yes
93.853EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL D...$366,679Yes
93.855ALLERGY AND INFECTIOUS DISEASES RESEARCH$338,309Yes
93.866AGING RESEARCH$317,419Yes
93.847DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$300,925Yes
93.393CANCER CAUSE AND PREVENTION RESEARCH$291,410Yes
12.420MILITARY MEDICAL RESEARCH AND DEVELOPMENT$198,582Yes
93.866AGING RESEARCH$181,609Yes
93.393CANCER CAUSE AND PREVENTION RESEARCH$173,847Yes
93.855ALLERGY AND INFECTIOUS DISEASES RESEARCH$130,764Yes
93.394CANCER DETECTION AND DIAGNOSIS RESEARCH$122,927Yes
47.074BIOLOGICAL SCIENCES$105,099Yes
12.420MILITARY MEDICAL RESEARCH AND DEVELOPMENT$100,000Yes
97.RDCHEMICAL AND BIOLOGICAL RESEARCH$87,604Yes
93.853EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL D...$86,699Yes
93.853EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL D...$80,905Yes
93.855ALLERGY AND INFECTIOUS DISEASES RESEARCH$75,068Yes
93.395CANCER TREATMENT RESEARCH$75,023Yes
93.866AGING RESEARCH$60,593Yes
93.855ALLERGY AND INFECTIOUS DISEASES RESEARCH$54,975Yes
93.866AGING RESEARCH$53,870Yes
93.837CARDIOVASCULAR DISEASES RESEARCH$53,067Yes

What findings did the auditor report?

The reference is the auditor’s; the requirement is the Compliance Supplement category the auditor selected. The finding text itself is not reproduced here; the FAC report linked above carries it in full. What the two severity levels mean: material weakness vs significant deficiency.

Findings on the most recent report
ReferenceRequirementSeverityRepeat
2016-001Procurement and suspension and debarment (I)Significant deficiencyNo

Form 990 and IRS registration

Form 990 "accounting fees" (Part IX line 11c) cover all accounting services reported by the organization and are not the price of an audit engagement.

Where to find the return itself, and what our Form 990 data covers: Form 990 lookup.

Most recent return
990 for 2025-09
Total revenue
$75,913,310
Total assets
$136,062,120
Accounting fees (Part IX line 11c)
$409,900
IRS object id
202612259349301821
NTEE code
H90
Exempt under
501(c)(3)
Ruling year
2002
BMF release
2026-10-20

Read next

How we computed this

Every row comes from the Federal Audit Clearinghouse record named beside it, one report per audit year, with a resubmission superseding the filing it replaces. The auditor is the one named on that filing — it is not a statement about who audits THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE AND AFFILIATES now. Form 990 figures come from the IRS e-filed return named by its object id. This page exists because the organization filed at least two single audits, or one with a finding.

Cite this page

AuditRadar. “The Translational Genomics Research Single Audit FY2016 (AZ).” https://getauditradar.com/single-audits/az/the-translational-genomics-research-institute-and-affiliates-753065445/. Data as of 2026-11-06.